BBC News - Thursday, 6 September, 2001
Scientists cannot tell what is causing the unexpected effect, but believe it is possible that the hepatitis may be hindering the spread of HIV.
The discovery may prove to be another way doctors can attack the Aids virus.
There are several main types of virus given the hepatitis name - the best known are A, B and C, all of which can have a serious impact on human health.
However, the latest research involves hepatitis G, which was only identified in the mid 1990s, and which is not believed to cause long-term harm to patients.
In the latest issue of the New England Journal of Medicine, researchers from the University of Iowa College of Medicine in the US carried out testing in humans, and laboratory experiments.
They found that where HIV patients were also infected with hepatitis G, they tended to live longer.
More likely to die
In fact, HIV patients without hepatitis G were 3.6 times more likely to die over a two-year period than those who had the second virus.
Dr Jack Stapleton, who led the study, said: "This leads us to believe that GBV-C (hepatitis G) is one factor explaining how some people live longer and more healthily with their HIV infection than other HIV-infected people do."
Their laboratory experiments added weight to the idea that the hepatitis virus may be having a direct effect on HIV.
They put both together in a cell culture, and found that cells infected with both viruses produced 30% to 40% less HIV than those infected with only HIV.
Dr Stapleton said: "We are now working to understand precisely how GBV-C inhibits HIV from growing.
"We do not know whether GBV directly interferes with HIV, or if the GBV stimulates cellular proteins, such as interferon or immune cytokines, that protect the cells from HIV growth."
Professor John Summerfield, from St Mary's Hospital in London, said the discovery was "very exciting".
"It's a very unexpected phenomenon - certainly patients who have HIV and hepatitis B or C tend to do worse."
He said that it was uncertain whether the inhibition of the HIV was something caused directly by the hepatitis G virus, or whether people who could carry the hepatitis virus over long periods had some other as yet unknown advantage.
010906
BB010903
Copyright © 2001 - BBC. Reproduction of this article (other than one copy for personal reference) must be cleared through the BBC.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.
.